About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Il2ratm1Dw
targeted mutation 1, Dennis M Willerford
MGI:1857192
Summary 7 genotypes


Genotype
MGI:3759842
hm1
Allelic
Composition		 Il2ratm1Dw/Il2ratm1Dw
Genetic
Background		 B6.129S4-Il2ratm1Dw
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il2ratm1Dw mutation (3 available); any Il2ra mutation (51 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging

immune system
abnormal T cell activation ( J:125748 )
• over 80% of the T cells from bone marrow chimeras (mutant bone marrow in Rag2-deficient hosts) exhibit an activated phenotype
abnormal regulatory T cell physiology ( J:125748 )
• bone marrow chimeras (mutant bone marrow in Rag2-deficient hosts) die within 40-50 days of autoimmune disorders
• however, when bone marrow chimeras receive 105 CD25-positive CD4-positive wild-type T cells two weeks after reconstitution they live past six months of age without any symptoms of autoimmune disorder
• premature death can also be prevented by including 50% normal or Il2tm1Hor bone marrow during reconstitution
lymphoid hyperplasia ( J:125748 )
• some bone marrow chimeras (mutant bone marrow in Rag2-deficient hosts) have enlarged lymph nodes containing up to 3 x 108 lymphocytes

hematopoietic system
anemia ( J:125748 )
• bone marrow chimeras (mutant bone marrow in Rag2-deficient hosts) exhibit anemia
abnormal T cell activation ( J:125748 )
• over 80% of the T cells from bone marrow chimeras (mutant bone marrow in Rag2-deficient hosts) exhibit an activated phenotype
abnormal regulatory T cell physiology ( J:125748 )
• bone marrow chimeras (mutant bone marrow in Rag2-deficient hosts) die within 40-50 days of autoimmune disorders
• however, when bone marrow chimeras receive 105 CD25-positive CD4-positive wild-type T cells two weeks after reconstitution they live past six months of age without any symptoms of autoimmune disorder
• premature death can also be prevented by including 50% normal or Il2tm1Hor bone marrow during reconstitution

growth/size/body
decreased body size ( J:125748 )
• bone marrow chimeras (mutant bone marrow in Rag2-deficient hosts) exhibit decreased body weight due to an autoimmune disorder




Genotype
MGI:5883306
hm2
Allelic
Composition		 Il2ratm1Dw/Il2ratm1Dw
Genetic
Background		 B6.129S4-Il2ratm1Dw/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il2ratm1Dw mutation (3 available); any Il2ra mutation (51 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
digestive/alimentary system
abnormal salivary gland morphology ( J:125129 )
• severe acinar gland destruction
abnormal salivary gland duct morphology ( J:125129 )
• mild ductal changes in the salivary gland
large intestinal inflammation ( J:125129 )
• severe inflammation in the colon
decreased salivation ( J:125129 )
• mice exhibit an increase in the lag time and a reduction of saliva production when treated with Pilocarpine, indicating loss of salivary gland function
salivary gland inflammation ( J:125129 )
• severe inflammation in the salivary glands
• major population of infiltrating leukocytes are lymphocytes and to a much lower extent neutrophils
• salivary glands show presence of a large fraction of T cells and a ratio of CD4+/CD8+ of 1/2
• although more Gr-1+ cells are seen in the salivary glands, the absolute number of neutrophils is relatively small

endocrine/exocrine glands
abnormal salivary gland morphology ( J:125129 )
• severe acinar gland destruction
abnormal salivary gland duct morphology ( J:125129 )
• mild ductal changes in the salivary gland
decreased salivation ( J:125129 )
• mice exhibit an increase in the lag time and a reduction of saliva production when treated with Pilocarpine, indicating loss of salivary gland function
salivary gland inflammation ( J:125129 )
• severe inflammation in the salivary glands
• major population of infiltrating leukocytes are lymphocytes and to a much lower extent neutrophils
• salivary glands show presence of a large fraction of T cells and a ratio of CD4+/CD8+ of 1/2
• although more Gr-1+ cells are seen in the salivary glands, the absolute number of neutrophils is relatively small
lacrimal gland inflammation ( J:125129 )
• severe inflammation in the lacrimal glands

homeostasis/metabolism
decreased salivation ( J:125129 )
• mice exhibit an increase in the lag time and a reduction of saliva production when treated with Pilocarpine, indicating loss of salivary gland function

immune system
large intestinal inflammation ( J:125129 )
• severe inflammation in the colon
salivary gland inflammation ( J:125129 )
• severe inflammation in the salivary glands
• major population of infiltrating leukocytes are lymphocytes and to a much lower extent neutrophils
• salivary glands show presence of a large fraction of T cells and a ratio of CD4+/CD8+ of 1/2
• although more Gr-1+ cells are seen in the salivary glands, the absolute number of neutrophils is relatively small
lacrimal gland inflammation ( J:125129 )
• severe inflammation in the lacrimal glands
lung inflammation ( J:125129 )
• severe lung inflammation
• however, mice do not exhibit skin inflammation

respiratory system
lung inflammation ( J:125129 )
• severe lung inflammation
• however, mice do not exhibit skin inflammation

vision/eye
lacrimal gland inflammation ( J:125129 )
• severe inflammation in the lacrimal glands

Mouse Models of Human Disease
 DO ID OMIM ID(s) Ref(s)
Sjogren's syndrome DOID:12894 OMIM:270150
 J:125129




Genotype
MGI:2179512
hm3
Allelic
Composition		 Il2ratm1Dw/Il2ratm1Dw
Genetic
Background		 involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il2ratm1Dw mutation (3 available); any Il2ra mutation (51 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:64279 )
• about 25% die between 8 and 20 weeks of age with severe anemia

hematopoietic system
enlarged spleen ( J:64279 )
• develop enlargement of the spleen between 4 and 6 weeks of age
hemolytic anemia ( J:64279 )
• develops as mice age
increased lymphocyte cell number ( J:64279 )
• polyclonal expansion of lymphocytes beginning between 4 and 6 weeks of age
abnormal T cell morphology ( J:64279 )
• T cells are slightly larger than in wild-type in adults, however T and B cell development is normal up to 4 weeks after birth
increased memory T cell number ( J:64279 )
• increased numbers of cells bearing marker for memory cells
increased IgA level ( J:64279 )
• 5- to 30-fold increase in IgA
increased IgG level ( J:64279 )
• 5- to 30-fold increase in IgG1, IgG2a, and IgG2b
abnormal T cell physiology ( J:64279 )
• proliferative responses to CD3 are reduced in T cells
• peripheral deletion of staphylococcal enterotoxin B (SEB)-reactive T cells is impaired

immune system
colitis ( J:64279 )
• starting at 12-16 weeks of age, develop severe bowel inflammation that is confined to the colon
increased lymphocyte cell number ( J:64279 )
• polyclonal expansion of lymphocytes beginning between 4 and 6 weeks of age
abnormal T cell morphology ( J:64279 )
• T cells are slightly larger than in wild-type in adults, however T and B cell development is normal up to 4 weeks after birth
increased memory T cell number ( J:64279 )
• increased numbers of cells bearing marker for memory cells
increased IgA level ( J:64279 )
• 5- to 30-fold increase in IgA
increased IgG level ( J:64279 )
• 5- to 30-fold increase in IgG1, IgG2a, and IgG2b
abnormal T cell physiology ( J:64279 )
• proliferative responses to CD3 are reduced in T cells
• peripheral deletion of staphylococcal enterotoxin B (SEB)-reactive T cells is impaired
enlarged spleen ( J:64279 )
• develop enlargement of the spleen between 4 and 6 weeks of age
enlarged lymph nodes ( J:64279 )
• develop enlargement of the lymph nodes between 4 and 6 weeks of age

digestive/alimentary system
diarrhea ( J:64279 )
• starts at 12-16 weeks of age as mice develop inflammatory bowel disease
colitis ( J:64279 )
• starting at 12-16 weeks of age, develop severe bowel inflammation that is confined to the colon

growth/size/body
cachexia ( J:64279 )
• starts at 12-16 weeks of age as mice develop inflammatory bowel disease
enlarged spleen ( J:64279 )
• develop enlargement of the spleen between 4 and 6 weeks of age

Mouse Models of Human Disease
 DO ID OMIM ID(s) Ref(s)
inflammatory bowel disease DOID:0050589 OMIM:PS266600
 J:64279




Genotype
MGI:4356291
cx4
Allelic
Composition		 Faslpr/Faslpr
Il2ratm1Dw/Il2ratm1Dw
Tg(CD2-Ccdc86)1Hfuj/?
Genetic
Background		 B6.Cg-Il2ratm1Dw Faslpr Tg(CD2-Ccdc86)1Hfuj
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (82 available)
Il2ratm1Dw mutation (3 available); any Il2ra mutation (51 available)
Tg(CD2-Ccdc86)1Hfuj mutation (1 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
enlarged spleen ( J:151722 )
• absence of the Fas receptor prevents the transgene from rescuing the splenomegaly associated with Il2ratm1Dw homozygotes

hematopoietic system
enlarged spleen ( J:151722 )
• absence of the Fas receptor prevents the transgene from rescuing the splenomegaly associated with Il2ratm1Dw homozygotes

growth/size/body
enlarged spleen ( J:151722 )
• absence of the Fas receptor prevents the transgene from rescuing the splenomegaly associated with Il2ratm1Dw homozygotes




Genotype
MGI:4356290
cx5
Allelic
Composition		 Il2ratm1Dw/Il2ratm1Dw
Tg(CD2-Ccdc86)1Hfuj/?
Genetic
Background		 B6.Cg-Il2ratm1Dw Tg(CD2-Ccdc86)1Hfuj
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il2ratm1Dw mutation (3 available); any Il2ra mutation (51 available)
Tg(CD2-Ccdc86)1Hfuj mutation (1 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
immune system phenotype ( J:151722 )
N
• the presence of the transgene prevents the splenomegaly, the large number of T cells, and high circulating levels of IL-17 normally found in Il2ratm1Dw homozygotes
increased activated T cell number ( J:151722 )
• high expression of CD44 and CD69 suggests the transgene does not prevent the aberrant activation of peripheral T cells

hematopoietic system
increased activated T cell number ( J:151722 )
• high expression of CD44 and CD69 suggests the transgene does not prevent the aberrant activation of peripheral T cells




Genotype
MGI:3760115
cx6
Allelic
Composition		 Il2ratm1Dw/Il2ratm1Dw
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
Genetic
Background		 C.Cg-Il2ratm1Dw Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il2ratm1Dw mutation (3 available); any Il2ra mutation (51 available)
Tg(Pgk1-HA)1.1Vbo mutation (0 available)
Tg(Tcra/Tcrb)1Vbo mutation (1 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
decreased regulatory T cell number ( J:112603 )
• CD25-positive CD4 T cells were almost completely absent in the lymph nodes and spleen, indicating that IL2 signaling is needed to maintain this regulatory T subset
increased regulatory T cell number ( J:112603 )
• the thymus, there is a substantial increase in the frequency and absolute numbers of CD25-positive CD4 T cells that have the characteristics of regulatory T cells
• this phenotype is similar to transgenic mice that have the Il2ra locus intact, indicating that IL2 signalling is not needed to generate this regulatory T cell subset
abnormal regulatory T cell physiology ( J:112603 )
• CD25-positive CD4 T cells from the thymus have a reduced capacity to suppress T cell proliferation in vitro

hematopoietic system
decreased regulatory T cell number ( J:112603 )
• CD25-positive CD4 T cells were almost completely absent in the lymph nodes and spleen, indicating that IL2 signaling is needed to maintain this regulatory T subset
increased regulatory T cell number ( J:112603 )
• the thymus, there is a substantial increase in the frequency and absolute numbers of CD25-positive CD4 T cells that have the characteristics of regulatory T cells
• this phenotype is similar to transgenic mice that have the Il2ra locus intact, indicating that IL2 signalling is not needed to generate this regulatory T cell subset
abnormal regulatory T cell physiology ( J:112603 )
• CD25-positive CD4 T cells from the thymus have a reduced capacity to suppress T cell proliferation in vitro




Genotype
MGI:5141604
cx7
Allelic
Composition		 Cdk6tm2.1Phin/Cdk6tm2.1Phin
Il2ratm1Dw/Il2ratm1Dw
Genetic
Background		 involves: 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdk6tm2.1Phin mutation (1 available); any Cdk6 mutation (40 available)
Il2ratm1Dw mutation (3 available); any Il2ra mutation (51 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
hematopoietic system phenotype ( J:174697 )
N
• mice exhibit normal thymocyte cellularity and accumulation in DN3 stage compared to in Cdk6tm1.1Phin homozygotes
increased hematopoietic stem cell number ( J:174697 )
• compared with control and Cdk6tm2.1Phin homozygotes

immune system




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory